AIM2-driven inflammasome activation in heart failure

Abstract Aims Interleukin-1β (IL-1β) is an important pathogenic factor in cardiovascular diseases including chronic heart failure (HF). The CANTOS trial highlighted that inflammasomes as primary sources of IL-1 β are promising new therapeutic targets in cardiovascular diseases. Therefore, we aimed t...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular research Vol. 117; no. 13; pp. 2639 - 2651
Main Authors: Onódi, Zsófia, Ruppert, Mihály, Kucsera, Dániel, Sayour, Alex Ali, Tóth, Viktória E, Koncsos, Gábor, Novák, Julianna, Brenner, Gábor B, Makkos, András, Baranyai, Tamás, Giricz, Zoltán, Görbe, Anikó, Leszek, Przemyslaw, Gyöngyösi, Mariann, Horváth, Iván G, Schulz, Rainer, Merkely, Béla, Ferdinandy, Péter, Radovits, Tamás, Varga, Zoltán V
Format: Journal Article
Language:English
Published: England Oxford University Press 22.11.2021
Subjects:
ISSN:0008-6363, 1755-3245, 1755-3245
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first